MRC CeCa.
Methods | RCT 1991‐1995 | |
Participants | 48 (0*) FIGO stage IB‐IVA | |
Interventions | CT RT or S vs RT or S CT: CDDP 50mg/m2 MTX 100 mg/m2 Folinic acid 15mg po/6h 30 after start of CDDP and MTX. Every 14 days for 3 cycles. RT: External beam 46Gy in 23F over 32 days. Intracavitary 20Gy |
|
Outcomes | Survival Disease‐free survival Locor‐regional disease‐free survival Metastases‐free survival | |
Notes | Treatment comparison 1 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Low risk | A ‐ Adequate |